Similarly, Perez-Soler et al., using an IgG2 mouse monoclonal antibody, and Modjtahedi et al., using an IgG2 rat monoclonal antibody, targeted EGFR in patients with lung cancer and squamous cell carcinoma of the head and neck without significant toxicity [55, 56]. This evidence concerns the gene EGFR and lung cancer.